AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ)
$32.29 0.2 (0.6232%)
Analysed AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ) News Sources
Amylyx (AMLX) Climbs to Fresh High as Avexitide Moves Closer to Commercialization
18-08-2026
yahoo.com
Why Did AMLX, IOVA, OKE Stocks Hit 52-Week Highs Today?
19-08-2026
stocktwits.com
Amylyx Pharmaceuticals (AMLX) Posts Phase 3 Avexitide Win And Follows With Equity Raise
19-08-2026
yahoo.com
Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock
20-08-2026
yahoo.com
Why Did IOVA, AMLX And COP Stocks Surge To 52-Week Highs Today?
21-08-2026
stocktwits.com
Amylyx (AMLX) Faces a Binary Phase 3 Test. Can Avexitide Rebuild the Company?
21-08-2026
yahoo.com
Why Amylyx Pharmaceuticals Blasted Nearly 79% Higher This Week
21-08-2026
fool.com
Is GLP-1 Stock Amylyx Still a Buy After Skyrocketing 247%?
01-09-2026
fool.com
Amylyx Pharmaceuticals to Present at the 24th Annual Morgan Stanley Global Healthcare Conference
08-09-2026
yahoo.com
Tortugas Neuroscience Announces Appointment of Jim Frates to Board of Directors
09-09-2026
yahoo.com
What is the current price of AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ)?
The current price of AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ) is $32.29.
AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ) absolute price change since previous trading day?
The absolute price change of AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ) since the previous trading day is $0.2.
AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ) percentage price change since previous trading day?
The percentage price change of AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ) since the previous trading day is 0.6232%.
What is the most recent average sentiment score for AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ)?
The most recent average sentiment score for AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ)?
The most recent sentiment for AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ) is .
SEC-8K** Filing Available For AMYLYX PHARMACEUTICALS INC (AMLX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.